RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 76 filers reported holding RA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,609,000 | -9.3% | 75,181 | -11.3% | 0.01% | +55.6% |
| Q4 2019 | $3,980,000 | +65.5% | 84,800 | -16.6% | 0.01% | +50.0% |
| Q3 2019 | $2,405,000 | -13.7% | 101,700 | +9.7% | 0.01% | -14.3% |
| Q2 2019 | $2,787,000 | +71.6% | 92,700 | +27.9% | 0.01% | +75.0% |
| Q1 2019 | $1,624,000 | +95.2% | 72,500 | +58.6% | 0.00% | +100.0% |
| Q4 2018 | $832,000 | +10.3% | 45,700 | +9.6% | 0.00% | 0.0% |
| Q3 2018 | $754,000 | +25.0% | 41,700 | -31.2% | 0.00% | 0.0% |
| Q2 2018 | $603,000 | +555.4% | 60,600 | +248.3% | 0.00% | – |
| Q1 2018 | $92,000 | – | 17,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|